Ann: Investor Presentation, page-117

	Study Type  :	Interventional  (Clinical Trial)
1	Estimated Enrollment  :	360 participants
2	Allocation:	Randomized
3	Intervention Model:	Parallel Assignment
4	Masking:	Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
5	Primary Purpose:	Treatment
6	Official Title:	A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris
7	Actual Study Start Date  :	June 26, 2018
8	Estimated Primary Completion Date  :	February 2019
9	Estimated Study Completion Date  :	March 2019